Related Experiment Video

Updated: Jun 23, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer

Vijayabaskar Lakshmikanthan1, Lin Zou, Jae I Kim

  • 1Department of Pathology, Medical College of Georgia, Augusta, GA 30912, USA.

Proceedings of the National Academy of Sciences of the United States of America
|May 22, 2009
PubMed

Insights

Beta-arrestin2 acts as a corepressor for the androgen receptor (AR) in prostate cancer cells. It promotes AR degradation, reducing prostate-specific antigen (PSA) gene expression and impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Androgen receptor (AR) signaling is crucial for prostate function and cancer development.
  • AR deregulation is implicated in prostate cancer initiation and progression to hormone-refractory disease.
  • Beta-arrestins are emerging as key signal transducers in both cellular compartments.

Purpose of the Study:

  • To investigate the role of beta-arrestin2 in androgen receptor signaling within prostate cancer cells.
  • To determine if beta-arrestin2 functions as a coregulator of the androgen receptor.
  • To elucidate the mechanism by which beta-arrestin2 influences androgen receptor activity and prostate cancer progression.

Main Methods:

  • Co-immunoprecipitation to detect protein complex formation between beta-arrestin2 and AR.
  • RNA interference (RNAi) to knock down beta-arrestin2 expression.
  • Quantitative analysis of prostate-specific antigen (PSA) gene expression.
  • Western blotting to assess AR ubiquitylation and degradation.
  • Analysis of human prostate tissue samples to correlate beta-arrestin2 and PSA expression.

Main Results:

  • Beta-arrestin2 forms a complex with the androgen receptor (AR) in prostate cancer cells.
  • Overexpression of beta-arrestin2 decreases AR activity, while its knockdown increases androgen-induced prostate-specific antigen (PSA) gene expression.
  • Beta-arrestin2 facilitates the ubiquitylation and degradation of AR by recruiting the Mdm2 E3 ligase.
  • Human prostate tissues show an inverse correlation between beta-arrestin2 levels and AR activity (PSA expression).

Conclusions:

  • Beta-arrestin2 functions as an androgen receptor (AR) corepressor in prostate cancer.
  • Beta-arrestin2 promotes AR degradation through a mechanism involving Mdm2-mediated ubiquitylation.
  • The findings suggest beta-arrestin2 as a potential therapeutic target for managing AR-driven prostate cancers.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...